Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation.
BACKGROUND
After stent-related vascular injury, an inflammatory response triggers the mobilization of bone marrow-derived stem cells, including both endothelial and smooth muscle progenitors, leading to re-endothelialization as well as restenosis. It has been postulated that neutrophil-released matrix metalloproteinase-9 (MMP-9) induces stem cell mobilization.


OBJECTIVE
To elucidate the mechanistic link between inflammation and stem cell mobilization after coronary stenting.


METHODS
In 31 patients undergoing coronary stenting, we serially measured activated Mac-1 on the surface of neutrophils and active MMP-9 levels in the coronary sinus blood plasma, and the number of circulating CD34-positive cells in the peripheral blood.


RESULTS
After bare-metal stent implantation (n=21), significant increases in the numbers of CD34-positive cells (maximum on post-procedure day 7, P<0.001), activated Mac-1 (at 48 h, P<0.001), and active MMP-9 levels (at 24h, P<0.001) were observed. However, these changes were absent after sirolimus-eluting stent implantation (n=10). In overall patients, the numbers of CD34-positive cells on day 7 (R=0.58, P<0.01) and activated Mac-1 at 48 h (R=0.58, P<0.01) were both correlated with active MMP-9 levels at 24h. Stimulation of activated Mac-1 on the surface of isolated human neutrophils produced active MMP-9 release in vitro.


CONCLUSIONS
These results suggest that stent-induced activation of Mac-1 on the surface of neutrophils might trigger their MMP-9 release, possibly leading to the mobilization of bone marrow-derived stem cells. These reactions were substantially inhibited by sirolimus-eluting stents.
Inoue
Teruo
T
Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi, Japan. inouet@dokkyomed.ac.jp
Taguchi
Isao
I
Abe
Shichiro
S
Toyoda
Shigeru
S
Nakajima
Kohsuke
K
Sakuma
Masashi
M
Node
Koichi
K
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation; D018952:Antigens, CD34 / Q000096:biosynthesis; D001854:Bone Marrow Cells / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology; D003324:Coronary Artery Disease / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D016177:Macrophage-1 Antigen / Q000096:biosynthesis; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D015607:Stents / Q000009:adverse effects
D018952:Antigens, CD34; D016177:Macrophage-1 Antigen; D020780:Matrix Metalloproteinase 9